Cormedix Inc (CRMD) Directors and Executive Officers - CSIMarket
CSIMarket
 
Cormedix Inc   (NASDAQ: CRMD)

Cormedix Inc

Officers & Directors




Current key executives:
- Dr. Khoso Baluch, CEO and President
- Matt J. David, Chief Financial Officer
- Dr. Andrey Alekseev, Chief Scientific Officer
- Dr. Robert Recio, Chief Medical Officer
- Gary Gelbfish, MD, Head of Clinical Research and Development

Current directors:
- Janet A

Cormedix Inc currently has 191 employees.

  News about Cormedix Inc Key Personnel

DefenCath: Pioneering the Fight Against Life-Threatening Infections

CorMedix Inc. Sets the Stage for Life-Saving Breakthrough with Commercial and Operational Updates
Berkeley Heights, N.J., Jan. 08, 2024 - CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company dedicated to developing and commercializing therapeutic products for preventing and treating life-threatening diseases and conditions, has recently divulged a series of commercial and operational updates that are poised to revolutionize the healthcare landscape. With the highly anticipated launch of their groundbreaking product, DefenCath, CorMedix Inc. is charting a new course in the fight against life-threatening infections.
DefenCath, CorMedix s flagship product, is a cutting-edge therapeutic catheter l...






CRMD Management Effectiveness CRMD Revenue per Employee CRMD Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.